The Durability of Response and Persistence of Resistance to AbbVie's 2 Direct-acting Antiviral Agent (2D) Therapy in Japanese Subjects

NCT02581020 · clinicaltrials.gov ↗
COMPLETED
Status
344
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

AbbVie